CA2419224A1 - Composes heterocycliques se liant avec les recepteurs de chimiokines - Google Patents

Composes heterocycliques se liant avec les recepteurs de chimiokines Download PDF

Info

Publication number
CA2419224A1
CA2419224A1 CA002419224A CA2419224A CA2419224A1 CA 2419224 A1 CA2419224 A1 CA 2419224A1 CA 002419224 A CA002419224 A CA 002419224A CA 2419224 A CA2419224 A CA 2419224A CA 2419224 A1 CA2419224 A1 CA 2419224A1
Authority
CA
Canada
Prior art keywords
mmol
tetrahydro
benzenedimethanamine
quinolinyl
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002419224A
Other languages
English (en)
Inventor
Gary Bridger
Dominique Schols
Renato Skerlj
Al Kaller
Curtis Harwig
David Earl Bogucki
Trevor R. Wilson
Jason Crawford
Maria Rosaria Di Fluri
Bem Atsma
Yuanxi Zhou
Ernest J. Mceachern
Siqiao Nan
Christopher Dennis Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2419224A1 publication Critical patent/CA2419224A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

L'invention concerne de nouveaux composés utiles pour le ciblage des récepteurs de chimiokines. Ces composés sont des amines tertiaires complexes.
CA002419224A 2000-09-15 2001-09-17 Composes heterocycliques se liant avec les recepteurs de chimiokines Abandoned CA2419224A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23289100P 2000-09-15 2000-09-15
US60/232,891 2000-09-15
US23451000P 2000-09-22 2000-09-22
US60/234,510 2000-09-22
PCT/CA2001/001326 WO2002022600A2 (fr) 2000-09-15 2001-09-17 Composes heterocycliques se liant avec les recepteurs de chimiokines

Publications (1)

Publication Number Publication Date
CA2419224A1 true CA2419224A1 (fr) 2002-03-21

Family

ID=26926422

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002419224A Abandoned CA2419224A1 (fr) 2000-09-15 2001-09-17 Composes heterocycliques se liant avec les recepteurs de chimiokines

Country Status (22)

Country Link
US (3) US6864265B2 (fr)
EP (1) EP1317445B1 (fr)
JP (1) JP2004508422A (fr)
KR (1) KR20030029998A (fr)
CN (1) CN1457339A (fr)
AT (1) ATE425157T1 (fr)
AU (2) AU2001291569B2 (fr)
BR (1) BR0113930A (fr)
CA (1) CA2419224A1 (fr)
DE (1) DE60137944D1 (fr)
ES (1) ES2325909T3 (fr)
HK (1) HK1052011A1 (fr)
HU (1) HUP0301093A2 (fr)
IL (1) IL154227A0 (fr)
MX (1) MXPA03002326A (fr)
NO (1) NO20031179L (fr)
NZ (1) NZ524420A (fr)
PL (1) PL360932A1 (fr)
RU (1) RU2289581C2 (fr)
SG (1) SG126007A1 (fr)
TR (1) TR200300322T2 (fr)
WO (1) WO2002022600A2 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1317451E (pt) 2000-09-15 2006-12-29 Anormed Inc Compostos heterocíclicos que se ligam a receptores de quimioquinas
US6835731B2 (en) * 2000-09-15 2004-12-28 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
CA2419224A1 (fr) 2000-09-15 2002-03-21 Anormed Inc. Composes heterocycliques se liant avec les recepteurs de chimiokines
US7169750B2 (en) 2001-07-31 2007-01-30 Anormed, Inc. Methods to mobilize progenitor/stem cells
ES2380009T3 (es) 2001-07-31 2012-05-07 Genzyme Global S.A.R.L. Métodos para movilizar las células madre/progenitoras
US7354932B2 (en) 2001-12-21 2008-04-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
CA2467718C (fr) * 2001-12-21 2011-04-26 Anormed Inc. Composes heterocycliques a efficacite accrue se fixant sur les recepteurs de la chimiokine
CN100528846C (zh) * 2002-09-11 2009-08-19 株式会社吴羽 胺化合物及其用途
EP1608352B1 (fr) 2003-04-02 2009-12-30 Taigen Biotechnology Composes polyamine pour le traitement de maladies induites par le recepteur de la chemokine
US7504422B2 (en) 2003-04-02 2009-03-17 Taigen Biotechnology Co. Ltd. Polyamine compounds
EP1613613B1 (fr) 2003-04-11 2021-06-02 Genzyme Corporation Composes de liaison aux recepteurs de chimiokine cxcr4
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
AU2004232361A1 (en) 2003-04-22 2004-11-04 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
US7501518B2 (en) 2003-04-22 2009-03-10 Genzyme Corporation Methods of making 2,6-diaryl piperidine derivatives
CA2534649A1 (fr) * 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Derives de l'imidazole bicycliques diriges contre les flaviviridae
US7498346B2 (en) 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
EP1708703A4 (fr) 2003-12-11 2008-04-09 Anormed Inc Composes de liaison aux recepteurs de la chemokine
US7932281B2 (en) 2004-03-10 2011-04-26 Kureha Corporation Amine-based compound and use thereof
CN1930127B (zh) * 2004-03-15 2012-11-21 阿诺麦德股份有限公司 用于合成cxcr4拮抗剂的方法
AU2005230846A1 (en) * 2004-03-31 2005-10-20 Lexicon Pharmaceuticals, Inc. 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
JP2008509928A (ja) * 2004-08-13 2008-04-03 アノーメド インコーポレイテッド 前駆／幹細胞を動員するためのケモカインの組み合わせ
CA2577100A1 (fr) * 2004-08-16 2006-03-02 Smithkline Beecham Corporation Composes chimiques
KR101210126B1 (ko) * 2004-08-19 2012-12-07 콜게이트-파아므올리브캄파니 구조화된 계면활성제 배합물 유래의 증진된 오일 전달
WO2006022454A1 (fr) * 2004-08-27 2006-03-02 Ono Pharmaceutical Co., Ltd Composé contenant un groupe basique et utilisation
JP2008511669A (ja) * 2004-09-02 2008-04-17 スミスクライン ビーチャム コーポレーション 化合物
WO2006036816A2 (fr) * 2004-09-24 2006-04-06 Smithkline Beecham Corporation Composes chimiques
TW200619206A (en) * 2004-09-29 2006-06-16 Anormed Inc Chemokine-binding heterocyclic compound salts, and methods of use thereof
ZA200705872B (en) * 2005-01-14 2008-09-25 Genelabs Tecnologies Inc Indole derivatives for treating viral infections
US7501526B2 (en) 2005-01-20 2009-03-10 Taigen Biotechnology Synthesis of polyamine compounds
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
EP1942890A4 (fr) 2005-06-15 2009-08-26 Genzyme Corp Composes de liaison au recepteur de la chimiokine
US20080214562A1 (en) * 2005-07-11 2008-09-04 Kristjan Gudmundsson Chemical Compounds
CA2619828A1 (fr) 2005-08-19 2007-02-22 Genzyme Corporation Methodes permettant d'augmenter l'efficacite d'une chimiotherapie
WO2007058322A1 (fr) * 2005-11-18 2007-05-24 Ono Pharmaceutical Co., Ltd. Composé contenant un groupe basique et son utilisation
US7807704B2 (en) * 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
US7671069B2 (en) 2006-03-30 2010-03-02 Chemocentryx, Inc. Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7
EP2042503B1 (fr) * 2006-05-16 2013-01-30 Ono Pharmaceutical Co., Ltd. Composé ayant un groupe acide qui peut être protégé et utilisation dudit composé
AU2007281090A1 (en) * 2006-08-02 2008-02-07 Genzyme Corporation Combination therapy
JP2010507567A (ja) * 2006-08-07 2010-03-11 ジェンザイム・コーポレーション 併用療法
US20110105477A1 (en) * 2007-09-14 2011-05-05 The Regents Of The University Of Michigan Compositions and methods relating to hiv protease inhibition
BRPI0913879A2 (pt) * 2008-07-02 2019-09-24 Hoffmann La Roche fenilpirazinonas como inibidores de quinase
EP2337563B1 (fr) * 2008-09-08 2014-04-09 The Board of Trustees of The Leland Stanford Junior University Modulateurs de l'activité de l'aldéhyde déshydrogénase et leurs procédés d'utilisation
EP3153510B1 (fr) 2010-12-03 2020-05-06 Emory University Azines fusiones comme modulateurs du récepteur de chimiokine cxcr4 et utilisations associées
CN102603683B (zh) * 2012-02-10 2014-04-09 山东大学 一种呋喃类化合物及其制备方法与应用
CN104478795A (zh) * 2014-11-24 2015-04-01 苏州乔纳森新材料科技有限公司 一种2-氯烟醛的制备方法
CA3026154A1 (fr) 2015-06-03 2016-12-08 The University Of Queensland Agents mobilisateurs et leurs utilisations
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
BR112018007021B1 (pt) * 2015-10-06 2024-01-09 Proteostasis Therapeutics, Inc Composto, composição compreendendo os ditos compostos e uso dos mesmos para tratar fibrose cística
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
WO2017106332A1 (fr) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Méthodes de traitement du cancer
CN109069426B (zh) 2015-12-14 2021-10-29 X4 制药有限公司 治疗癌症的方法
PL3393468T3 (pl) 2015-12-22 2023-01-23 X4 Pharmaceuticals, Inc. Metody leczenia niedoboru odporności
US11337969B2 (en) 2016-04-08 2022-05-24 X4 Pharmaceuticals, Inc. Methods for treating cancer
ES2870920T3 (es) 2016-06-21 2021-10-28 X4 Pharmaceuticals Inc Inhibidores de CXCR4 y usos de los mismos
WO2017223243A1 (fr) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Inhibiteurs de cxcr4 et leurs utilisations
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
WO2018073248A1 (fr) 2016-10-17 2018-04-26 Icm (Institut Du Cerveau Et De La Moelle Épinière) Pronostic de patients souffrant de maladies démyélinisantes et traitement associé
US20210315909A1 (en) 2018-07-11 2021-10-14 Arrys Therapeutics, Inc. Polymorphic compounds and uses thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
GB201910608D0 (en) * 2019-07-24 2019-09-04 Enterprise Therapeutics Ltd Compounds
CA3171250A1 (fr) 2020-03-10 2021-09-16 E. Lynne KELLEY Methodes de traitement de la neutropenie
WO2021215544A1 (fr) * 2020-04-24 2021-10-28 Taiho Pharmaceutical Co., Ltd. Inhibiteurs de protéine kras g12d
CN112110853A (zh) * 2020-09-23 2020-12-22 海南梵圣生物科技有限公司 一种合成3-羟基-2-吡啶甲酸及其衍生物的方法
CN116375650B (zh) * 2022-12-30 2025-08-05 浙江美诺华药物化学有限公司 一种替戈拉生中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2024516C1 (ru) * 1989-02-02 1994-12-15 Яманути Фармасьютикал Ко., Лтд. Способ получения производного тетрагидробензимидазола или его фармацевтически приемлемой соли
US5021409A (en) 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
US6001826A (en) 1989-12-21 1999-12-14 Anormed, Inc. Chemical compounds
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
GB9400411D0 (en) 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
GB9511357D0 (en) 1995-06-06 1995-08-02 Johnson Matthey Plc Improved antiviral compounds
EP1015440A1 (fr) 1997-07-16 2000-07-05 Ciba SC Holding AG Spiro composes du type polyglycidyle et leur utilisation dans des resines epoxy
WO1999038514A1 (fr) * 1998-02-02 1999-08-05 Merck & Co., Inc. Amines cycliques utilisees en tant que modulateurs de l'activite du recepteur de chemokine
JPH11269146A (ja) * 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
WO2000042852A1 (fr) * 1999-01-25 2000-07-27 Smithkline Beecham Corporation Composes et procedes
WO2000051607A1 (fr) * 1999-03-02 2000-09-08 Merck & Co., Inc. Modulateurs de l'activite recepteur des chimiokines, a base de 3-cyclopropyle et 3-cyclobutyle
BR0010655A (pt) * 1999-03-24 2002-02-13 Anormed Inc Compostos heterocìclicos para ligação ao receptor de quimiocina
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
CA2419224A1 (fr) * 2000-09-15 2002-03-21 Anormed Inc. Composes heterocycliques se liant avec les recepteurs de chimiokines
US6835731B2 (en) * 2000-09-15 2004-12-28 Anormed, Inc. Chemokine receptor binding heterocyclic compounds

Also Published As

Publication number Publication date
IL154227A0 (en) 2003-07-31
ATE425157T1 (de) 2009-03-15
BR0113930A (pt) 2003-06-24
ES2325909T3 (es) 2009-09-24
EP1317445A2 (fr) 2003-06-11
US20040220207A1 (en) 2004-11-04
CN1457339A (zh) 2003-11-19
AU2001291569B2 (en) 2007-07-26
US6864265B2 (en) 2005-03-08
HK1052011A1 (zh) 2003-08-29
US7084155B2 (en) 2006-08-01
AU9156901A (en) 2002-03-26
WO2002022600A2 (fr) 2002-03-21
NO20031179D0 (no) 2003-03-14
EP1317445B1 (fr) 2009-03-11
RU2289581C2 (ru) 2006-12-20
MXPA03002326A (es) 2003-06-06
US7396840B2 (en) 2008-07-08
WO2002022600A3 (fr) 2002-05-10
KR20030029998A (ko) 2003-04-16
PL360932A1 (en) 2004-09-20
JP2004508422A (ja) 2004-03-18
NO20031179L (no) 2003-03-14
DE60137944D1 (de) 2009-04-23
NZ524420A (en) 2005-04-29
SG126007A1 (en) 2006-10-30
US20060128750A1 (en) 2006-06-15
TR200300322T2 (tr) 2003-09-22
US20030018046A1 (en) 2003-01-23
HUP0301093A2 (hu) 2003-09-29

Similar Documents

Publication Publication Date Title
EP1317445B1 (fr) Composes heterocycliques se liant avec les recepteurs de chimiokines
AU2001291569A1 (en) Chemokine receptor binding heterocyclic compounds
AU2001294628B2 (en) Chemokine receptor binding heterocyclic compounds
EP1317443B1 (fr) Composes heterocycliques se liant avec les recepteurs de chimiokines
US20040209921A1 (en) CXCR4 chemokine receptor binding comounds
US20070066624A1 (en) Chemokine receptor binding compounds
AU2001294628A1 (en) Chemokine receptor binding heterocyclic compounds
AU2001293551A1 (en) Chemokine receptor binding heterocyclic compounds
EP1244648B1 (fr) Recepteur de chemokine liant des composes heterocycliques
JP2004512336A (ja) ケモカインレセプター結合複素環式化合物
RU2297413C2 (ru) Гетероциклические соединения, моделирующие активность хемокинового рецептора, их применение и содержащая их фармацевтическая композиция
RU2277092C2 (ru) Гетероциклические соединения, их применение и фармацевтическая композиция для лечения состояний, опосредованных схсr4 и ccr5
HK1059257B (en) Chemokine receptor binding heterocyclic compounds
MXPA03002327A (es) Compuestos heterociclicos que se unen a receptor de quimiocina.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued